CCEL Q2 2024 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q2 2024 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+3.5% YoY

Gross Profit

$6M74.8% margin

Operating Income

$1M17.3% margin

Net Income

$655,7908.2% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$911,785

Stock-Based Comp.

$178,139

Balance Sheet

Total Assets

$63M

Total Liabilities

$73M

Stockholders' Equity

-$11M

Cash & Equivalents

$469,195

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+3.5%
Gross Profit	$6M	$6M	+6.9%
Operating Income	$1M	$1M	+35.4%
Net Income	$655,790	$220,976	+196.8%

Revenue Segments

Processing And Storage Fees

$8M99%

Public Banking

$41,4771%

Product

$35,8340%